BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28290728)

  • 21. Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL).
    Jung SH; Lee JJ; Kim WS; Lee WS; Do YR; Oh SY; Kim MK; Mun YC; Shin HJ; Kwak JY; Kang HJ; Won JH; Kwon JH; Park E; Suh C; Yang DH
    Eur J Haematol; 2015 Jun; 94(6):504-10. PubMed ID: 25288018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffuse aggressive lymphoma.
    Fisher RI; Miller TP; O'Connor OA
    Hematology Am Soc Hematol Educ Program; 2004; ():221-36. PubMed ID: 15561685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary.
    Morrison VA; Hamlin P; Soubeyran P; Stauder R; Wadhwa P; Aapro M; Lichtman SM
    Ann Oncol; 2015 Jun; 26(6):1058-1068. PubMed ID: 25635006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with diffuse large B-cell lymphoma: an Australian retrospective analysis.
    Millar A; Ellis M; Mollee P; Cochrane T; Fletcher J; Caudron A; Webster B; Trotman J
    Intern Med J; 2015 Nov; 45(11):1147-53. PubMed ID: 26337606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics and outcomes in diffuse large B cell lymphoma patients aged 70 years and older: a single-center experience with a literature review.
    Jung YH; Woo IS; Han CW
    Korean J Intern Med; 2015 Sep; 30(5):684-93. PubMed ID: 26354063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What determines therapeutic choices for elderly patients with DLBCL? Clinical findings of a multicenter study in Portugal.
    Alvarez R; Esteves S; Chacim S; Carda J; Mota A; Guerreiro M; Barbosa I; Moita F; Teixeira A; Coutinho J; Príncipe F; Mariz JM; Silva MG
    Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):370-9. PubMed ID: 24629852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New developments in the management of diffuse large B-cell lymphoma.
    Habermann TM
    Hematology; 2012 Apr; 17 Suppl 1():S93-7. PubMed ID: 22507791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma.
    Laribi K; Denizon N; Bolle D; Truong C; Besançon A; Sandrini J; Anghel A; Farhi J; Ghnaya H; Baugier de Materre A
    Ann Hematol; 2016 Oct; 95(10):1705-14. PubMed ID: 27485454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.
    Lugtenburg P; Silvestre AS; Rossi FG; Noens L; Krall W; Bendall K; Szabo Z; Jaeger U
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):297-305. PubMed ID: 23040435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using the pathology report in initial treatment decisions for diffuse large B-cell lymphoma: time for a precision medicine approach.
    Friedberg JW
    Hematology Am Soc Hematol Educ Program; 2015; 2015():618-24. PubMed ID: 26637779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study.
    Nowakowski GS; LaPlant B; Macon WR; Reeder CB; Foran JM; Nelson GD; Thompson CA; Rivera CE; Inwards DJ; Micallef IN; Johnston PB; Porrata LF; Ansell SM; Gascoyne RD; Habermann TM; Witzig TE
    J Clin Oncol; 2015 Jan; 33(3):251-7. PubMed ID: 25135992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
    Coiffier B; Lepage E; Briere J; Herbrecht R; Tilly H; Bouabdallah R; Morel P; Van Den Neste E; Salles G; Gaulard P; Reyes F; Lederlin P; Gisselbrecht C
    N Engl J Med; 2002 Jan; 346(4):235-42. PubMed ID: 11807147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective Analysis of Treatment Outcomes and Geriatric Assessment in Elderly Malignant Lymphoma Patients.
    Naito Y; Sasaki H; Takamatsu Y; Kiyomi F; Tamura K
    J Clin Exp Hematop; 2016; 56(1):43-9. PubMed ID: 27334857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of rituximab for the treatment of diffuse large B-cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the german high-grade non-Hodgkin lymphoma study group.
    Pfreundschuh M; Poeschel V; Zeynalova S; Hänel M; Held G; Schmitz N; Viardot A; Dreyling MH; Hallek M; Mueller C; Wiesen MH; Witzens-Harig M; Truemper L; Keller U; Rixecker T; Zwick C; Murawski N
    J Clin Oncol; 2014 Dec; 32(36):4127-33. PubMed ID: 25403207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: results of the PRO-R-IPI study.
    Panizo C; Rodríguez AJ; Gutiérrez G; Díaz FJ; González-Barca E; de Oña R; Grande C; Sancho JM; García-Álvarez MF; Sánchez-González B; Peñalver FJ; Cannata J; Espeso M; Requena MJ; Gardella S; Durán S; González AP; Alfonso A; Caballero MD;
    Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):398-403. PubMed ID: 25843416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapy.
    Ciammella P; Filippi AR; Simontacchi G; Buglione M; Furlan C; Spina M; Tucci A; Rigacci L; Iotti C; Vitolo U; Ricardi U; Merli F
    Leuk Lymphoma; 2016 Nov; 57(11):2677-80. PubMed ID: 26926887
    [No Abstract]   [Full Text] [Related]  

  • 38. R-split-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma.
    Kreher S; Lammer F; Augustin D; Pezzutto A; Baldus CD
    Eur J Haematol; 2014 Jul; 93(1):70-6. PubMed ID: 24612334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients.
    González-Barca E; Canales MA; Salar A; Ferrer S; Domingo-Domenech E; Vidal MJ; Grande C; Bargay J; Gardella S; Oriol A; Briones J; García-Frade J; Bello JL; Sánchez-Blanco JJ; Peñalver FJ; Tomás JF; Asensio A; López A; Caballero D;
    Acta Haematol; 2016; 136(2):76-84. PubMed ID: 27188649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving outcomes for patients with diffuse large B-cell lymphoma.
    Flowers CR; Sinha R; Vose JM
    CA Cancer J Clin; 2010; 60(6):393-408. PubMed ID: 21030533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.